Value of survival gains in chronic myeloid leukemia.

The American journal of managed care

Volumn 18, Issue 11 Suppl, 2012, Pages

  Yin, Wesley ^a   Penrod, John R ^b   Maclean, Ross ^b   Lakdawalla, Darius N ^b   Philipson, Thomas ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

ADULT; AGED; ANTAGONISTS AND INHIBITORS; CANCER REGISTRY; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; INSURANCE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SOCIAL PSYCHOLOGY; SURVIVAL;

ADULT; AGED; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; SEER PROGRAM; SOCIAL VALUES; SURVIVAL ANALYSIS;

EID: 84891440972     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)